메뉴 건너뛰기




Volumn 106, Issue 4, 1999, Pages 851-859

Management of relapsed acute myeloid leukaemia

Author keywords

Acute myeloid leukaemia; AML relapse; AML therapy

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; CYCLOSPORIN; CYTARABINE; DEOXYADENOSINE DERIVATIVE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; VALSPODAR; VERAPAMIL;

EID: 0032845556     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01629.x     Document Type: Review
Times cited : (40)

References (110)
  • 1
    • 0026323802 scopus 로고
    • Results of therapy for acute myeloid leukemia in first relapse
    • Angelov, L., Brandwein, J.M. & Baker, M.A. (1991) Results of therapy for acute myeloid leukemia in first relapse. Leukemia and Lymphoma, 6, 15-19.
    • (1991) Leukemia and Lymphoma , vol.6 , pp. 15-19
    • Angelov, L.1    Brandwein, J.M.2    Baker, M.A.3
  • 2
    • 0030665228 scopus 로고    scopus 로고
    • Long-term survival after chemotherapy for acute myeloid leukemia: The experience of the Southwest Oncology Group
    • Appelbaum, F.R. & Kopecky, K.J. (1997) Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group. Cancer. 80, (Suppl.), 2199-2204.
    • (1997) Cancer , vol.80 , Issue.SUPPL. , pp. 2199-2204
    • Appelbaum, F.R.1    Kopecky, K.J.2
  • 4
    • 0025275742 scopus 로고
    • Randomised multi-center trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL)
    • Arlin, Z., Case, D.C., Moore, J., Wiernik, P., Feldman, E., Saletan, S., Desai, P., Sai, L., & Cartwright, K., (1990) Randomised multi-center trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Leukemia. 4, 177-183.
    • (1990) Leukemia , vol.4 , pp. 177-183
    • Arlin, Z.1    Case, D.C.2    Moore, J.3    Wiernik, P.4    Feldman, E.5    Saletan, S.6    Desai, P.7    Sai, L.8    Cartwright, K.9
  • 7
    • 0026340666 scopus 로고
    • Second transplants for leukaemic relapse after bone marrow transplantation: High early mortality but favourable effect of chronic GvHD on continued remission. A report by the EBMT Leukaemia Working Party
    • Barrett, A.J., Locatelli, E., Treleaven, J.G., Gratwohl, A., Szyldo, R. & Zwaan, F.E. (1991) Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GvHD on continued remission. A report by the EBMT Leukaemia Working Party. British Journal of Haematology. 79, 567-574.
    • (1991) British Journal of Haematology , vol.79 , pp. 567-574
    • Barrett, A.J.1    Locatelli, E.2    Treleaven, J.G.3    Gratwohl, A.4    Szyldo, R.5    Zwaan, F.E.6
  • 8
    • 0025907179 scopus 로고
    • Results of a randomised trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
    • Berman, E., Raymond, Z., Daghestani, A., Arlin, Z.A., Gee, T.S., Kempin, S., Hancock, C., Williams, L., Stevens, Y.W., Clarkson, B.D., & Young, C. (1991) Results of a randomised trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood, 77, 1666-1674.
    • (1991) Blood , vol.77 , pp. 1666-1674
    • Berman, E.1    Raymond, Z.2    Daghestani, A.3    Arlin, Z.A.4    Gee, T.S.5    Kempin, S.6    Hancock, C.7    Williams, L.8    Stevens, Y.W.9    Clarkson, B.D.10    Young, C.11
  • 10
    • 16944363396 scopus 로고    scopus 로고
    • Second allogeneic: Bone marrow transplantation in acute leukemia: A multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo
    • Bosi, A., Bacci, S., Miniero, R., Locatelli, F., Laszlo, D., Longo, G., Busca, A., van Lint, M.T., Di Bartolomeo, P. & Amici, A. (1997) Second allogeneic: bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo. Leukemia, 11, 420-424.
    • (1997) Leukemia , vol.11 , pp. 420-424
    • Bosi, A.1    Bacci, S.2    Miniero, R.3    Locatelli, F.4    Laszlo, D.5    Longo, G.6    Busca, A.7    Van Lint, M.T.8    Di Bartolomeo, P.9    Amici, A.10
  • 11
    • 0028920312 scopus 로고
    • High dose etoposide, cyclophosphamide and total body irradiation with bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: A study by the North American marrow transplant group
    • Brown, R.A., Wolff, S.N., Fay, J.W., Pinicro, L., Collins, R.H., Lynch, J.P., Stevens, D., Greer, J., Herzig, R.M. & Herzig, G.P. (1995) High dose etoposide, cyclophosphamide and total body irradiation with bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American marrow transplant group. Blood, 85, 1391-1395.
    • (1995) Blood , vol.85 , pp. 1391-1395
    • Brown, R.A.1    Wolff, S.N.2    Fay, J.W.3    Pinicro, L.4    Collins, R.H.5    Lynch, J.P.6    Stevens, D.7    Greer, J.8    Herzig, R.M.9    Herzig, G.P.10
  • 12
    • 10144257875 scopus 로고    scopus 로고
    • High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: A study by the North American Marrow Transplant Group
    • Brown, R.A., Wolff, S.N., Fay, J.W., Pineiro, L. Collins, R.H., Lynch, J.P., Stevens, D., Greer, J., Herzig, R.H., & Herzig, G.P. (1996) High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. Leukemia and Lymphoma, 22, 271-277.
    • (1996) Leukemia and Lymphoma , vol.22 , pp. 271-277
    • Brown, R.A.1    Wolff, S.N.2    Fay, J.W.3    Pineiro, L.4    Collins, R.H.5    Lynch, J.P.6    Stevens, D.7    Greer, J.8    Herzig, R.H.9    Herzig, G.P.10
  • 13
    • 0029918790 scopus 로고    scopus 로고
    • The role of prognostic factors in acute myeloid leukemia
    • Buchmer, T. & Heinecke, A. (1996) The role of prognostic factors in acute myeloid leukemia. Leukemia, 10, (Suppl. 1), S28-S29.
    • (1996) Leukemia , vol.10 , Issue.SUPPL. 1
    • Buchmer, T.1    Heinecke, A.2
  • 16
    • 0032492441 scopus 로고    scopus 로고
    • Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AMT, 10 trial
    • Burnett, A.K., Goldstone, A.H., Stevens, R.M.F., Hann, I.M., Rees, J.K.H., Gray, R.G. & Wheatley, K. (1998) Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AMT, 10 trial. Lancet. 351, 700-707.
    • (1998) Lancet , vol.351 , pp. 700-707
    • Burnett, A.K.1    Goldstone, A.H.2    Stevens, R.M.F.3    Hann, I.M.4    Rees, J.K.H.5    Gray, R.G.6    Wheatley, K.7
  • 17
    • 0028905531 scopus 로고
    • Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance
    • Campana, D. & Pui, C.H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood. 85, 1416-1434.
    • (1995) Blood , vol.85 , pp. 1416-1434
    • Campana, D.1    Pui, C.H.2
  • 20
    • 0026050884 scopus 로고
    • Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: The British autograft group experience
    • Chopra, R., Goldstone, A.H. & MacMillan, A.K. (1991) Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience. Journal of Clinical Oncology. 9, 1840-1847.
    • (1991) Journal of Clinical Oncology , vol.9 , pp. 1840-1847
    • Chopra, R.1    Goldstone, A.H.2    Macmillan, A.K.3
  • 22
    • 0030041952 scopus 로고    scopus 로고
    • The novel immunomodulator, Linomide, stimulates interleukin-2-induced natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors
    • Condiotti, R., Slavin, S., Barak, V. & Nagler, A. (1996) The novel immunomodulator, Linomide, stimulates interleukin-2-induced natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors. Leukemia Research, 20, 57-63.
    • (1996) Leukemia Research , vol.20 , pp. 57-63
    • Condiotti, R.1    Slavin, S.2    Barak, V.3    Nagler, A.4
  • 23
    • 0025292912 scopus 로고
    • Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78
    • Creutzig, U., Ritter, J. & Schellong, G. (1990) Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood, 75, 1452-1940.
    • (1990) Blood , vol.75 , pp. 1452-1940
    • Creutzig, U.1    Ritter, J.2    Schellong, G.3
  • 24
    • 4243890085 scopus 로고    scopus 로고
    • A phase 1 trial of liposomul daunorubicin (daunoxome) administered with high dose cytarabine (HiDAC) to patients with relapsed acute, leukemia
    • Cripe, L., Kneebone, P., Roberts, L., Mukwaya, G., Rutledge, C. & Gordon, M. (1998) A phase 1 trial of liposomul daunorubicin (daunoxome) administered with high dose cytarabine (HiDAC) to patients with relapsed acute, leukemia, Blood, 90. (Suppl. 1). 233a.
    • (1998) Blood , vol.90 , Issue.SUPPL. 1
    • Cripe, L.1    Kneebone, P.2    Roberts, L.3    Mukwaya, G.4    Rutledge, C.5    Gordon, M.6
  • 25
    • 0026541166 scopus 로고
    • Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: Feasibility of using busulphan alone for re-conditioning
    • Cullis, J.O., Schwarer, A.P., Hughes, T.P., Hows, J.M., Franklin, I., Morgenstern, G. & Goldman, J.M. (1992) Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning. British Journal of Haematology. 80, 33-39.
    • (1992) British Journal of Haematology , vol.80 , pp. 33-39
    • Cullis, J.O.1    Schwarer, A.P.2    Hughes, T.P.3    Hows, J.M.4    Franklin, I.5    Morgenstern, G.6    Goldman, J.M.7
  • 26
    • 85069113070 scopus 로고    scopus 로고
    • A stratification system for evaluating therapies in patients with relapsed or primary refractory myeloid leukemia
    • Estey, E., Kornblau, S. & Pierce, S. (1996) A stratification system for evaluating therapies in patients with relapsed or primary refractory myeloid leukemia. Blood. 88, 756.
    • (1996) Blood , vol.88 , pp. 756
    • Estey, E.1    Kornblau, S.2    Pierce, S.3
  • 27
    • 0028344644 scopus 로고
    • Use of granulocyte colony stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with fludarabine plus cytarabine without grarmlocyte colony stimulating factor
    • Estey, E., Thall, P., Andreeff, M., Beran, M., Kantarjian, H., O'Brien, S., Escudier, S., Robertson, L.E., Koller, C., Kornblau, S., Pierce, S., Freireich, E.J., Deisseroth, A. & Keating, M. (1994) Use of granulocyte colony stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without grarmlocyte colony stimulating factor. Journal of Clinical Oncology, 12, 672-678.
    • (1994) Journal of Clinical Oncology , vol.12 , pp. 672-678
    • Estey, E.1    Thall, P.2    Andreeff, M.3    Beran, M.4    Kantarjian, H.5    O'Brien, S.6    Escudier, S.7    Robertson, L.E.8    Koller, C.9    Kornblau, S.10    Pierce, S.11    Freireich, E.J.12    Deisseroth, A.13    Keating, M.14
  • 28
    • 4243893366 scopus 로고    scopus 로고
    • Randomised phase II trial of fludarabine + Ara-C + idarubicin ± all-trans retinoic acid (ATRA) ± G-CSF in poor prognosis newly-diagnosed AWT. and MDS
    • Estey, E., Thall, P., Pierce, S. & Freireich, E. (1998) Randomised phase II trial of fludarabine + Ara-C + idarubicin ± all-trans retinoic acid (ATRA) ± G-CSF in poor prognosis newly-diagnosed AWT. and MDS. Blood, 92, (Suppl. 1), 233a.
    • (1998) Blood , vol.92 , Issue.SUPPL. 1
    • Estey, E.1    Thall, P.2    Pierce, S.3    Freireich, E.4
  • 29
    • 0030861429 scopus 로고    scopus 로고
    • Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia
    • Falkenberg, J.H., Swit, W.M. & Williemze, R. (1997) Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunological Reviews, 157, 223-230.
    • (1997) Immunological Reviews , vol.157 , pp. 223-230
    • Falkenberg, J.H.1    Swit, W.M.2    Williemze, R.3
  • 31
    • 0031812317 scopus 로고    scopus 로고
    • IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), on effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: Experiences of a phase II trial
    • Fleischhack, G., Hasan, C., Graf, N., Mann, G. & Bode, U. (1998) IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), on effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial. British Journal of Haematology, 102, 647-655.
    • (1998) British Journal of Haematology , vol.102 , pp. 647-655
    • Fleischhack, G.1    Hasan, C.2    Graf, N.3    Mann, G.4    Bode, U.5
  • 34
    • 0025150433 scopus 로고
    • Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure
    • Gajewski, J.L., Ho, W.G. & Feig, S.A. (1990) Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure. Transplantation, 50, 244-249.
    • (1990) Transplantation , vol.50 , pp. 244-249
    • Gajewski, J.L.1    Ho, W.G.2    Feig, S.A.3
  • 37
    • 0025734611 scopus 로고
    • Minimal residual disease in acute leukaemia: Preclinical studies in a relevant rat model (BNML)
    • (ed. by C. Jasmin and S. J. Proctor). Balliere Tindall, London
    • Hagenbeck, A. & Martens. A.C.M. (1991) Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML). Balliere's Clinical Haematology (ed. by C. Jasmin and S. J. Proctor). p. 609. Balliere Tindall, London.
    • (1991) Balliere's Clinical Haematology , pp. 609
    • Hagenbeck, A.1    Martens, A.C.M.2
  • 38
    • 0030895252 scopus 로고    scopus 로고
    • Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults. Results of the Medical Research Council's 10th AMT, trial (AML 10)
    • Hann, L.M., Stevens, R.F., Goldstone, A.H., Wheatley, K. & Burnett, A. (1998) Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults. Results of the Medical Research Council's 10th AMT, trial (AML 10). Blood, 89, 2311-2318.
    • (1998) Blood , vol.89 , pp. 2311-2318
    • Hann, L.M.1    Stevens, R.F.2    Goldstone, A.H.3    Wheatley, K.4    Burnett, A.5
  • 40
    • 0041442548 scopus 로고
    • Results of a randomised double Wind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de novo acute mycloid leukemia
    • Heil, G., Hoelzer, D., Sanz, M.A., Lechner, K., Liu Yin, J., Papa, G., Noens, L., Ho, J., O'Brien, C., Matcham, J. & Barge, A. (1995) Results of a randomised double Wind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de novo acute mycloid leukemia. Blood, 86, (Suppl. 1), 267a.
    • (1995) Blood , vol.86 , Issue.SUPPL. 1
    • Heil, G.1    Hoelzer, D.2    Sanz, M.A.3    Lechner, K.4    Liu Yin, J.5    Papa, G.6    Noens, L.7    Ho, J.8    O'brien, C.9    Matcham, J.10    Barge, A.11
  • 42
    • 0025329042 scopus 로고
    • Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation: A case report of a probable graft-versus-leukemia effect
    • Higano, C.S., Brixey, M., Bryant, E.M., Durnam, D.M., Doney. K., Sullivan, K.M. & Singer. J.W. (1990) Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation: a case report of a probable graft-versus-leukemia effect. Transplantation. 50, 175-177.
    • (1990) Transplantation , vol.50 , pp. 175-177
    • Higano, C.S.1    Brixey, M.2    Bryant, E.M.3    Durnam, D.M.4    Doney, K.5    Sullivan, K.M.6    Singer, J.W.7
  • 43
    • 0025100777 scopus 로고
    • Graft-versus-leukemia reactions after bone marrow transplantation
    • Horowitz, M.M., Gale, R.P. & Sondel, P.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555-562.
    • (1990) Blood , vol.75 , pp. 555-562
    • Horowitz, M.M.1    Gale, R.P.2    Sondel, P.M.3
  • 44
    • 12644313240 scopus 로고    scopus 로고
    • FLAG (fludarabine, cytosine, arabinoside, G-CSFJ for refractory and relapsed acute leukemia
    • Huhmann, I.M., Watzke, H.H. & Geissler, K. (1996) FLAG (fludarabine, cytosine, arabinoside, G-CSFJ for refractory and relapsed acute leukemia. Annals of Hematology, 73, 256-271.
    • (1996) Annals of Hematology , vol.73 , pp. 256-271
    • Huhmann, I.M.1    Watzke, H.H.2    Geissler, K.3
  • 45
    • 0001279030 scopus 로고    scopus 로고
    • Potential for myeloablation with ytrium-90-labelled HuM195 (anti-CD33): A phase I trial in advanced myeloid leukemias
    • Jurcic, J.G., Divgi, C.R., McDevitt, M.R., Ma, D., Sgouros, G., Finn, R.D., Larson, S.M. & Scheinberg, D.A. (1998) Potential for myeloablation with ytrium-90-labelled HuM195 (anti-CD33): a phase I trial in advanced myeloid leukemias. Blood, 92, (Suppl. 1), 613a.
    • (1998) Blood , vol.92 , Issue.SUPPL. 1
    • Jurcic, J.G.1    Divgi, C.R.2    McDevitt, M.R.3    Ma, D.4    Sgouros, G.5    Finn, R.D.6    Larson, S.M.7    Scheinberg, D.A.8
  • 47
    • 0024379549 scopus 로고
    • Response to salvage therapy and survival after relapse in acute myelogenous leukemia
    • Keating, M.J., Kantarjian, H. & Smith, T.L. (1989) Response to salvage therapy and survival after relapse in acute myelogenous leukemia. Journal of Clinical Oncology. 7, 1071-1080.
    • (1989) Journal of Clinical Oncology , vol.7 , pp. 1071-1080
    • Keating, M.J.1    Kantarjian, H.2    Smith, T.L.3
  • 50
    • 0030916862 scopus 로고    scopus 로고
    • Donor leukocyte infusions for leukemic relapse after allogeneic marrow transplantation: Lack of residual donor hematopoiesis predicts aplasia
    • Keil, E., Haas, O.A., Fritsch, G., Kahls, P., Lechner, K., Mannhalter, C., Reiter, E., Niederweiser, D., Hoecker, P. & Greinix, H.T. (1997) Donor leukocyte infusions for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia. Blood, 89, 3113-3117.
    • (1997) Blood , vol.89 , pp. 3113-3117
    • Keil, E.1    Haas, O.A.2    Fritsch, G.3    Kahls, P.4    Lechner, K.5    Mannhalter, C.6    Reiter, E.7    Niederweiser, D.8    Hoecker, P.9    Greinix, H.T.10
  • 51
    • 17344366634 scopus 로고    scopus 로고
    • Superiority of high-dose over intermediate dose cytosine arabinoside in the treatment of patients with high risk acute myeloid leukemia: Results of an age-adjusted prospective randomised comparison
    • Kern, W. Aul, C., Maschmeyer, G., Schonrock-Nahulsi, R., Ludwig, W.D., Bartholomaus, A., Bettelheim, P., Wormann, B., Buchner, T. & Hiddemann, W, (1998) Superiority of high-dose over intermediate dose cytosine arabinoside in the treatment of patients with high risk acute myeloid leukemia: results of an age-adjusted prospective randomised comparison, Leukemia, 12, 1049-1055.
    • (1998) Leukemia , vol.12 , pp. 1049-1055
    • Kern, W.1    Aul, C.2    Maschmeyer, G.3    Schonrock-Nahulsi, R.4    Ludwig, W.D.5    Bartholomaus, A.6    Bettelheim, P.7    Wormann, B.8    Buchner, T.9    Hiddemann, W.10
  • 52
    • 85069108795 scopus 로고    scopus 로고
    • Different effects of all-trans retinoic acid and etoposide on down-regulation of bcl-2 in apoptosis associated with cytochrome C efflux and caspase activation in acute mycloblastic leukemia cells
    • Koistinen, P., Zheng, A., Siitonen, T., Mantymaa, P., Saily, M. & Savolainen, E.-R. (1998) Different effects of all-trans retinoic acid and etoposide on down-regulation of bcl-2 in apoptosis associated with cytochrome C efflux and caspase activation in acute mycloblastic leukemia cells. Blood, 92, (Suppl. 1), 600a.
    • (1998) Blood , vol.92 , Issue.SUPPL. 1
    • Koistinen, P.1    Zheng, A.2    Siitonen, T.3    Mantymaa, P.4    Saily, M.5    Savolainen, E.-R.6
  • 54
    • 0029744389 scopus 로고    scopus 로고
    • Clinical and laboratory studies of 2-chlorodeoxyadenosine ± cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults
    • Kornblau, S.M., Gandhi, V., Andreef, H.M., Beran, M., Kantarjian, H.M., Koller, C.A., O'Brien, S., Plunkett, W. & Estey, E. (1996) Clinical and laboratory studies of 2-chlorodeoxyadenosine ± cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults. Leukemia, 10, 1563-1569.
    • (1996) Leukemia , vol.10 , pp. 1563-1569
    • Kornblau, S.M.1    Gandhi, V.2    Andreef, H.M.3    Beran, M.4    Kantarjian, H.M.5    Koller, C.A.6    O'Brien, S.7    Plunkett, W.8    Estey, E.9
  • 55
    • 0028347630 scopus 로고
    • Late effects of intensive treatment for acute myeloid leukaemia and myelodysplasia in childhood
    • Liesner, R.J., Leiper, A.D., Hann, L.M. & Chessels, J.M. (1994) Late effects of intensive treatment for acute myeloid leukaemia and myelodysplasia in childhood. Journal of Clinical Oncology. 12, 916-924.
    • (1994) Journal of Clinical Oncology , vol.12 , pp. 916-924
    • Liesner, R.J.1    Leiper, A.D.2    Hann, L.M.3    Chessels, J.M.4
  • 57
    • 0030058445 scopus 로고    scopus 로고
    • Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia
    • List, A.F. (1996) Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia. 10, 937-942.
    • (1996) Leukemia , vol.10 , pp. 937-942
    • List, A.F.1
  • 58
    • 0000038344 scopus 로고    scopus 로고
    • Benefit of cyclosporine (CsA) modulation of anthracycline resistance in high-risk AML: A Southwest Oncology Group study
    • List, A.F., Kopecky, K.J., Willman, C.L., Spier, C., Dorr, R., Flaherty, L., Hynes, H. & Appelbaum, F. (1998) Benefit of cyclosporine (CsA) modulation of anthracycline resistance in high-risk AML: a Southwest Oncology Group study. Blood. 92, (Suppl. 1). 312a.
    • (1998) Blood , vol.92 , Issue.SUPPL. 1
    • List, A.F.1    Kopecky, K.J.2    Willman, C.L.3    Spier, C.4    Dorr, R.5    Flaherty, L.6    Hynes, H.7    Appelbaum, F.8
  • 63
    • 0030996274 scopus 로고    scopus 로고
    • Outcome of acute leukaemia relapsing after bone marrow transplantation: Utility of second transplants and adoptive immunotherapy
    • Mehta, J., Powles, R., Treleaven, J., Horton, C., Meller, S., Pinkerton, C.R. Singhal, S. (1997) Outcome of acute leukaemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplantation, 19, 709-719.
    • (1997) Bone Marrow Transplantation , vol.19 , pp. 709-719
    • Mehta, J.1    Powles, R.2    Treleaven, J.3    Horton, C.4    Meller, S.5    Pinkerton, C.R.6    Singhal, S.7
  • 64
    • 0028145247 scopus 로고
    • Interleukin 2 may induce prolonged remissions in advanced acute myelogenous leukemia
    • Meloni, G., Foa, R., Vignetti, M., Guarini, A., Fenu, S., Tosti, S., Tos, A.G. & Mandelli, F. (1994) Interleukin 2 may induce prolonged remissions in advanced acute myelogenous leukemia. Blood, 84, 2158-2163.
    • (1994) Blood , vol.84 , pp. 2158-2163
    • Meloni, G.1    Foa, R.2    Vignetti, M.3    Guarini, A.4    Fenu, S.5    Tosti, S.6    Tos, A.G.7    Mandelli, F.8
  • 65
    • 0029866914 scopus 로고    scopus 로고
    • Interleukin 2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: Updated experience with 20 cases
    • Meloni, G., Vignetti, M., Andrizzi, C., Capria, S., Foa, R. & Mandelli, F. (1996) Interleukin 2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 cases. Leukemia and Lymphoma, 21, 429-435.
    • (1996) Leukemia and Lymphoma , vol.21 , pp. 429-435
    • Meloni, G.1    Vignetti, M.2    Andrizzi, C.3    Capria, S.4    Foa, R.5    Mandelli, F.6
  • 66
    • 0027650626 scopus 로고
    • Long-term follow up of three cases of acute myeloid leukaemia with inv(16) (p13q22)
    • Miura, I., Cyubachi, A., Hashimoto, K., Nishinari, T., Nimura, T. & Miura, A.B. (1993) Long-term follow up of three cases of acute myeloid leukaemia with inv(16) (p13q22). Rinso-Ketsueki, 34, 942-945.
    • (1993) Rinso-Ketsueki , vol.34 , pp. 942-945
    • Miura, I.1    Cyubachi, A.2    Hashimoto, K.3    Nishinari, T.4    Nimura, T.5    Miura, A.B.6
  • 69
    • 0027317604 scopus 로고
    • Persistence of the 8:21 translocation in patients with acute myeloid leukemia type M2 in long-term remission
    • Nucifora, G., Larson, R.A. & Rowley, J.D. (1991) Persistence of the 8:21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood, 82, 712-715.
    • (1991) Blood , vol.82 , pp. 712-715
    • Nucifora, G.1    Larson, R.A.2    Rowley, J.D.3
  • 71
    • 0027196772 scopus 로고
    • Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with ifosfamide
    • Perot, C., van-den-Akker, J., Laporte, J.P., Douay, L., Lopez, M., Stachowiak, J., Isnard, F., Taillemite, J.L., Najman, A. & Gorin, N.C. (1993) Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with ifosfamide. Leukemia, 7, 509-515.
    • (1993) Leukemia , vol.7 , pp. 509-515
    • Perot, C.1    Van-Den-Akker, J.2    Laporte, J.P.3    Douay, L.4    Lopez, M.5    Stachowiak, J.6    Isnard, F.7    Taillemite, J.L.8    Najman, A.9    Gorin, N.C.10
  • 72
    • 0027245918 scopus 로고
    • Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission
    • Petersen, F.B., Lynch, M.H. & Clift, R.A. (1995) Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission, journal of Clinical Oncology. 11, 1353-1360.
    • (1995) Journal of Clinical Oncology , vol.11 , pp. 1353-1360
    • Petersen, F.B.1    Lynch, M.H.2    Clift, R.A.3
  • 73
    • 0026093499 scopus 로고
    • Determinants of response and prediction of response to chemotherapy in acute myelogenous leukaemia
    • Preisler, H.D. (1991) Determinants of response and prediction of response to chemotherapy in acute myelogenous leukaemia. Balliere's Clinical Haematology. 69-93.
    • (1991) Balliere's Clinical Haematology , pp. 69-93
    • Preisler, H.D.1
  • 76
    • 0027741362 scopus 로고
    • Treatment of minimal residual disease in myeloid leukemia: The immunotherapeutic options with emphasis on linomide
    • Rowe, J.M., Nilsson. B.I. & Simonsson, B. (1993) Treatment of minimal residual disease in myeloid leukemia: the immunotherapeutic options with emphasis on linomide. Leukemia and Lymphoma, 11, 321-329.
    • (1993) Leukemia and Lymphoma , vol.11 , pp. 321-329
    • Rowe, J.M.1    Nilsson, B.I.2    Simonsson, B.3
  • 79
    • 0026536178 scopus 로고
    • 2-chlorodeoxyadenosine produces a high rate of complete remission in relapsed acute myeloid leukemia
    • Santana, V.M., Mirro, J., Kearns, C., Schell, M.J., Crom, W., & Blakley, R.L. (1992) 2-Chlorodeoxyadenosine produces a high rate of complete remission in relapsed acute myeloid leukemia. Journal of Clinical Oncology. 10, 364-570.
    • (1992) Journal of Clinical Oncology , vol.10 , pp. 364-570
    • Santana, V.M.1    Mirro, J.2    Kearns, C.3    Schell, M.J.4    Crom, W.5    Blakley, R.L.6
  • 80
    • 4243570147 scopus 로고    scopus 로고
    • Peripheral blood progenitor cell (PBSC) versus bone marrow (BM) transplants from HLA-identical donors - A joint analysis of the International Bone Marrow Transplant Registry (IBMTR) and the European Group for Blood and Bone Marrow Transplantation (EBMT)
    • Schmitz, N., Champlin, R. Horowitz, M. & Gratwohl, A. (1998) Peripheral blood progenitor cell (PBSC) versus bone marrow (BM) transplants from HLA-identical donors - a joint analysis of the International Bone Marrow Transplant Registry (IBMTR) and the European Group for Blood and Bone Marrow Transplantation (EBMT). Bone Marrow Transplantation. 21. (Suppl. 1), S43.
    • (1998) Bone Marrow Transplantation , vol.21 , Issue.SUPPL. 1
    • Schmitz, N.1    Champlin, R.2    Horowitz, M.3    Gratwohl, A.4
  • 81
    • 0031884911 scopus 로고    scopus 로고
    • Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: A report from the Children's Cancer Group
    • Sievers, E.L., Lange, B.J., Sondel, P.M., Krailo, M.D., Gan, J., Liu-Mares, W. & Feig, S.A. (1998a) Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group, journal of Clinical Oncology, 16, 914-919.
    • (1998) Journal of Clinical Oncology , vol.16 , pp. 914-919
    • Sievers, E.L.1    Lange, B.J.2    Sondel, P.M.3    Krailo, M.D.4    Gan, J.5    Liu-Mares, W.6    Feig, S.A.7
  • 82
  • 83
    • 0032006125 scopus 로고    scopus 로고
    • Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
    • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or. R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 91, 756-763.
    • (1998) Blood , vol.91 , pp. 756-763
    • Slavin, S.1    Nagler, A.2    Naparstek, E.3    Kapelushnik, Y.4    Aker, M.5    Cividalli, G.6    Varadi, G.7    Kirschbaum, M.8    Ackerstein, A.9    Samuel, S.10    Amar, A.11    Brautbar, C.12    Ben-Tal, O.13    Eldor, A.14    Or, R.15
  • 85
    • 0031682976 scopus 로고    scopus 로고
    • Duration of first remission predicts remission rates and longterm survival in children with relapsed acute mycloid leukemia
    • Stahuke, K., Boos, J., Bender-Gotze, C., Ritter, J., Zimmermann, M. & Creutzig, U. (1998) Duration of first remission predicts remission rates and longterm survival in children with relapsed acute mycloid leukemia. Leukemia, 12, 1534-1538.
    • (1998) Leukemia , vol.12 , pp. 1534-1538
    • Stahuke, K.1    Boos, J.2    Bender-Gotze, C.3    Ritter, J.4    Zimmermann, M.5    Creutzig, U.6
  • 86
    • 0029963320 scopus 로고    scopus 로고
    • Therapy of refractory or recurrent childhood acute mycloid leukemia using amsacrine and etoposide with or without axacitidine: A Pediatric Oncology Group randomised phase II study
    • Steuber, C.P., Krischer, J., Holbrook, T., Camitta, B., Land, V., Sexauer, C., Mahoney, D, & Weinstein, H. (1996) Therapy of refractory or recurrent childhood acute mycloid leukemia using amsacrine and etoposide with or without axacitidine: a Pediatric Oncology Group randomised phase II study. Journal of Clinical Oncology. 14, 1521-1525.
    • (1996) Journal of Clinical Oncology , vol.14 , pp. 1521-1525
    • Steuber, C.P.1    Krischer, J.2    Holbrook, T.3    Camitta, B.4    Land, V.5    Sexauer, C.6    Mahoney, D.7    Weinstein, H.8
  • 87
    • 0031958821 scopus 로고    scopus 로고
    • Marked improvements in outcome with chemotherapy alone in paediatric acute mycloid leukaemia: Results of the United Kingdom Medical Research Council's 10th AML trial
    • Stevens, R.F., Hann, I.M., Wheatley, K. & Gray. R.C. (1998) Marked improvements in outcome with chemotherapy alone in paediatric acute mycloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. British Journal of Haematology. 101, 130-140.
    • (1998) British Journal of Haematology , vol.101 , pp. 130-140
    • Stevens, R.F.1    Hann, I.M.2    Wheatley, K.3    Gray, R.C.4
  • 88
    • 0024566585 scopus 로고
    • Influence of acute und chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia
    • Sullivan, K.M., Weiden, P.L. & Storb, R. (1989) Influence of acute und chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood, 73, 1720-1728.
    • (1989) Blood , vol.73 , pp. 1720-1728
    • Sullivan, K.M.1    Weiden, P.L.2    Storb, R.3
  • 91
    • 0005040904 scopus 로고    scopus 로고
    • A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin for other anthracyclines) as induction therapy for acute mycloid leukaemia
    • The AML Collaborative Group (1998) A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin for other anthracyclines) as induction therapy for acute mycloid leukaemia. British Journal of Haematology, 101, 100-109.
    • (1998) British Journal of Haematology , vol.101 , pp. 100-109
  • 93
    • 6844237003 scopus 로고    scopus 로고
    • Cost-effectiveness and quality of life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute mycloid leukaemia
    • Uyl de Groot, C.A., Lowenberg, B., Vellenga, E., Suciu, S., Willemze, R. & Rutten, F.F. (1998) Cost-effectiveness and quality of life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute mycloid leukaemia. British Journal of Haematology. 100, 629-636.
    • (1998) British Journal of Haematology , vol.100 , pp. 629-636
    • Uyl De Groot, C.A.1    Lowenberg, B.2    Vellenga, E.3    Suciu, S.4    Willemze, R.5    Rutten, F.F.6
  • 94
    • 0028102950 scopus 로고
    • Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute mycloid leukemia
    • Vahdat, L., Wong, E.T., Wile, M.J., Rosenblum, M., Foley, K.M. & Warrell, R.P. (1994) Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute mycloid leukemia. Blood. 84, 3429-3434.
    • (1994) Blood , vol.84 , pp. 3429-3434
    • Vahdat, L.1    Wong, E.T.2    Wile, M.J.3    Rosenblum, M.4    Foley, K.M.5    Warrell, R.P.6
  • 96
    • 0029395378 scopus 로고
    • Donor leukocyte transfusions for leukemic relapse
    • Van Rhee, F. & Kolb, H.J. (1995) Donor leukocyte transfusions for leukemic relapse. Current Opinion in Hematology, 2, 423-430.
    • (1995) Current Opinion in Hematology , vol.2 , pp. 423-430
    • Van Rhee, F.1    Kolb, H.J.2
  • 97
    • 4243243195 scopus 로고    scopus 로고
    • Effect of CR on survival in patients with AML receiving first salvage therapy
    • Vey, N., Keating. M.J., Rios, M.B. & Estey, E. (1998) Effect of CR on survival in patients with AML receiving first salvage therapy. Mood. 92, (Suppl. 1). 235a.
    • (1998) Mood , vol.92 , Issue.SUPPL. 1
    • Vey, N.1    Keating, M.J.2    Rios, M.B.3    Estey, E.4
  • 98
    • 0030451886 scopus 로고    scopus 로고
    • Probability of long-term disease-free survival for acute mycloid leukemia patients after first relapse: A single centre experience
    • Vignetti, M., Orsini, E., Petti, M.C., Moleti, M.L., Andrizzi. C., Pinto, R.M., Amadori, S. & Meloni, G. (1996) Probability of long-term disease-free survival for acute mycloid leukemia patients after first relapse: a single centre experience. Annals of Oncology. 7, 933-938.
    • (1996) Annals of Oncology , vol.7 , pp. 933-938
    • Vignetti, M.1    Orsini, E.2    Petti, M.C.3    Moleti, M.L.4    Andrizzi, C.5    Pinto, R.M.6    Amadori, S.7    Meloni, G.8
  • 99
    • 0026650021 scopus 로고
    • A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: A Southeastern Cancer Study Group trial
    • Vogler, W.R., Vefez-Garcia, E., Weiner, R.S., Flaum, M.A., Bartolucci, A.A., Omura, G.A., Gerber, M.C. & Banks, P.L. (1992) A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group trial. Journal of Clinical Oncology. 10, 1103-1111.
    • (1992) Journal of Clinical Oncology , vol.10 , pp. 1103-1111
    • Vogler, W.R.1    Vefez-Garcia, E.2    Weiner, R.S.3    Flaum, M.A.4    Bartolucci, A.A.5    Omura, G.A.6    Gerber, M.C.7    Banks, P.L.8
  • 100
    • 0032924997 scopus 로고    scopus 로고
    • Outcome for children with relapsed acute mycloid leukemia following initial therapy in the Medical Research Council (MRC) AML 10 trial
    • Webb, D.K.H., Wheatley, K., Harrison, G., Stevens, R.F. & Hann, I.M. (1999) Outcome for children with relapsed acute mycloid leukemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. Leukemia, 13, 25-31.
    • (1999) Leukemia , vol.13 , pp. 25-31
    • Webb, D.K.H.1    Wheatley, K.2    Harrison, G.3    Stevens, R.F.4    Hann, I.M.5
  • 101
    • 0019861205 scopus 로고
    • Antileukemic effect of graft-versus-host disease: Contribution to improved survival after allogeneic transplantation
    • Weiden, P.L., Sullivan, K.M. & Flournoy, N. (1981) Antileukemic effect of graft-versus-host disease: contribution to improved survival after allogeneic transplantation. New England Journal of Medicine, 304, 1529-1532.
    • (1981) New England Journal of Medicine , vol.304 , pp. 1529-1532
    • Weiden, P.L.1    Sullivan, K.M.2    Flournoy, N.3
  • 102
    • 0028132188 scopus 로고
    • Cytosine arabinoside und mitoxantronc induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemia
    • Wells, R.J., Gold, S.H., Krill, C.E., Cornelius, A.S., Byrd, R.L., Ruymann, F.B., White, M.L., Feuser, J. & Cairo, M.S. (1994) Cytosine arabinoside und mitoxantronc induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemia. Leukemia, 8, 1626-1630.
    • (1994) Leukemia , vol.8 , pp. 1626-1630
    • Wells, R.J.1    Gold, S.H.2    Krill, C.E.3    Cornelius, A.S.4    Byrd, R.L.5    Ruymann, F.B.6    White, M.L.7    Feuser, J.8    Cairo, M.S.9
  • 103
    • 85069098147 scopus 로고    scopus 로고
    • A simple, robust and highly predictive prognostic index for the determination of risk-directed therapy in acute mycloid leukemia derived from the MRC AML 10 trial
    • (in press)
    • Wheatley, K., Burnett, A.K., Goldstone, A.H., Gray, R.G., Hann, I.M., Harrison, C., Rees, J.K.H., Stevens, R.F. & Walker, H. (1999) A simple, robust and highly predictive prognostic index for the determination of risk-directed therapy in acute mycloid leukemia derived from the MRC AML 10 trial. Blood (in press).
    • (1999) Blood
    • Wheatley, K.1    Burnett, A.K.2    Goldstone, A.H.3    Gray, R.G.4    Hann, I.M.5    Harrison, C.6    Rees, J.K.H.7    Stevens, R.F.8    Walker, H.9
  • 104
    • 0031052815 scopus 로고    scopus 로고
    • High-dose cytosine arabinoside and etoposide: An effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia
    • Whitlock, J.A., Wells, R.J., Hord, J.D., Janco, R.L., Greer, J.P., Gay, J.C., Edwards, J.R., McCurley, T.L. & Lukens, J.N. (1997) High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia, Leukemia, 11, 185-189.
    • (1997) Leukemia , vol.11 , pp. 185-189
    • Whitlock, J.A.1    Wells, R.J.2    Hord, J.D.3    Janco, R.L.4    Greer, J.P.5    Gay, J.C.6    Edwards, J.R.7    McCurley, T.L.8    Lukens, J.N.9
  • 105
    • 0031452589 scopus 로고    scopus 로고
    • The prognostic significance of the epxression and function of multidrug resistance proteins in acute myeloid leukemia: Studies of the Southwest Oncology Group Leukemia Research Program
    • Willman, C.L., (1997) The prognostic significance of the epxression and function of multidrug resistance proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program. Seminars in Hematology. 34, (Suppl. 5), 25-33.
    • (1997) Seminars in Hematology , vol.34 , Issue.SUPPL. 5 , pp. 25-33
    • Willman, C.L.1
  • 106
    • 0028244591 scopus 로고
    • P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival
    • Wood, P., Burgess, R., MacGregor. A. & Liu Yin, J.A. (1994) P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival. British Journal of Haematology. 87, 509-514.
    • (1994) British Journal of Haematology , vol.87 , pp. 509-514
    • Wood, P.1    Burgess, R.2    Macgregor, A.3    Liu Yin, J.A.4
  • 108
    • 0029922321 scopus 로고    scopus 로고
    • Levels of mdr1 and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogenous and inversely correlated to cellular daunorubicin accumulation
    • Xu, D., Knaust, K., Pisa, P., Palucka, K., Lundeberg, J., Arestrom, I., Peterson, O. & Gruber, A. (1996) levels of mdr1 and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogenous and inversely correlated to cellular daunorubicin accumulation. British Journal of Haematology. 92, 847-854.
    • (1996) British Journal of Haematology , vol.92 , pp. 847-854
    • Xu, D.1    Knaust, K.2    Pisa, P.3    Palucka, K.4    Lundeberg, J.5    Arestrom, I.6    Peterson, O.7    Gruber, A.8
  • 109
    • 0026720403 scopus 로고
    • Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia
    • Yeager, A.M., Vogelsang, G.B., Jones, R.J., Farmer, E.R., Altomonte, V., Hess, A.D. & Santos, G.W. (1992) Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood. 79, 3031-3035.
    • (1992) Blood , vol.79 , pp. 3031-3035
    • Yeager, A.M.1    Vogelsang, G.B.2    Jones, R.J.3    Farmer, E.R.4    Altomonte, V.5    Hess, A.D.6    Santos, G.W.7
  • 110
    • 0003254672 scopus 로고    scopus 로고
    • Comparison of two chemotherapy regimens with or without cyclosporin A, in relapsed/refractory acute myeloid leukaemia: Results of the UK Medical Research Council AML-R trial
    • Yin, J.A.L., Wheatley, K., Rees, J. & Burnett, A.J. (1998) Comparison of two chemotherapy regimens with or without cyclosporin A, in relapsed/refractory acute myeloid leukaemia: results of the UK Medical Research Council AML-R trial. Blood, 92, (Suppl. 1). 231a.
    • (1998) Blood , vol.92 , Issue.SUPPL. 1
    • Yin, J.A.L.1    Wheatley, K.2    Rees, J.3    Burnett, A.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.